Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Novozymes Drops as Ethanol Turns Unprofitable: Copenhagen Mover

April 10 (Bloomberg) -- Novozymes A/S, the world’s largest maker of enzymes used for biofuel, was the second-biggest loser on Copenhagen’s benchmark index today on concern sales may suffer after U.S. ethanol production turned unprofitable.

Novozymes fell as much as 2.2 percent, the biggest decline in the Copenhagen 20 Index after Tryg A/S. Novozymes’ stock retreated 3.4 kroner, or 2.1 percent, to 161.70 kroner at 9:35 a.m. in the Danish capital.

Novozymes controls almost 60 percent of the U.S. market for enzymes used in biofuel production, and bioenergy enzymes accounted for 17 percent of the Bagsvaerd, Denmark-based company’s 2011 revenue. Ethanol futures yesterday fell to the lowest level in more than a week in Chicago trading.

With gasoline consumption waning, the U.S. is on course to miss its ethanol target for the first time and producers aren’t making money at current prices, according to Wallace Tyner, an agricultural economist at Purdue University in West Lafayette, Indiana. U.S. refiners are required to mix 13.2 billion gallons of renewable products with motor fuels this year, up 4.8 percent from last year.

To contact the reporters on this story: Christian Wienberg in Copenhagen at; Gelu Sulugiuc in Copenhagen at

To contact the editor responsible for this story: Tasneem Brogger at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.